Ace Pharmacology & Nursing Process 2025 – Dive in with Linda Lane Lilley!

Question: 1 / 400

What might result from concurrent use of aminocaproic acid and estrogens?

Decreased coagulation

Increased coagulation

Concurrent use of aminocaproic acid and estrogens can result in increased coagulation. Aminocaproic acid is an antifibrinolytic medication that prevents the breakdown of blood clots, while estrogens can increase the production of clotting factors in the blood. Therefore, using these two medications together can lead to an excessive and potentially dangerous increase in blood clotting. None of the other options, such as decreased coagulation, reduced blood pressure, or impaired wound healing, are known effects of using these medications together.

Get further explanation with Examzify DeepDiveBeta

Reduced blood pressure

Impaired wound healing

Next Question

Report this question

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy